nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.507	1	CbGbCtD
Flunitrazepam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0924	CcSEcCtD
Flunitrazepam—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0133	0.09	CbGeAlD
Flunitrazepam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0692	CcSEcCtD
Flunitrazepam—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0654	CcSEcCtD
Flunitrazepam—TSPO—appendage—amyotrophic lateral sclerosis	0.0114	0.0772	CbGeAlD
Flunitrazepam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00976	0.0658	CbGeAlD
Flunitrazepam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00916	0.0506	CcSEcCtD
Flunitrazepam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0475	CcSEcCtD
Flunitrazepam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00841	0.0464	CcSEcCtD
Flunitrazepam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00809	0.0447	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00786	0.0434	CcSEcCtD
Flunitrazepam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00759	0.0419	CcSEcCtD
Flunitrazepam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.0071	1	CrCbGaD
Flunitrazepam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00656	0.0443	CbGeAlD
Flunitrazepam—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0351	CcSEcCtD
Flunitrazepam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00634	0.0428	CbGeAlD
Flunitrazepam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0327	CcSEcCtD
Flunitrazepam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00559	0.0377	CbGeAlD
Flunitrazepam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0268	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00481	0.0265	CcSEcCtD
Flunitrazepam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0263	CcSEcCtD
Flunitrazepam—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0261	CcSEcCtD
Flunitrazepam—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00467	0.0258	CcSEcCtD
Flunitrazepam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0243	CcSEcCtD
Flunitrazepam—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0241	CcSEcCtD
Flunitrazepam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0238	CcSEcCtD
Flunitrazepam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0235	CcSEcCtD
Flunitrazepam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0228	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0226	CcSEcCtD
Flunitrazepam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0218	CcSEcCtD
Flunitrazepam—TSPO—embryo—amyotrophic lateral sclerosis	0.0038	0.0256	CbGeAlD
Flunitrazepam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00376	0.0254	CbGeAlD
Flunitrazepam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0208	CcSEcCtD
Flunitrazepam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0201	CcSEcCtD
Flunitrazepam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00364	0.0245	CbGeAlD
Flunitrazepam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0192	CcSEcCtD
Flunitrazepam—TSPO—brainstem—amyotrophic lateral sclerosis	0.00348	0.0235	CbGeAlD
Flunitrazepam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0168	CcSEcCtD
Flunitrazepam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00293	0.0198	CbGeAlD
Flunitrazepam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00284	0.0192	CbGeAlD
Flunitrazepam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00282	0.019	CbGeAlD
Flunitrazepam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0154	CcSEcCtD
Flunitrazepam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00276	0.0186	CbGeAlD
Flunitrazepam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00274	0.0185	CbGeAlD
Flunitrazepam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0147	CcSEcCtD
Flunitrazepam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0147	CcSEcCtD
Flunitrazepam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0146	CcSEcCtD
Flunitrazepam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00265	0.0179	CbGeAlD
Flunitrazepam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00258	0.0174	CbGeAlD
Flunitrazepam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00255	0.0172	CbGeAlD
Flunitrazepam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00254	0.0171	CbGeAlD
Flunitrazepam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00248	0.0167	CbGeAlD
Flunitrazepam—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00243	0.0164	CbGeAlD
Flunitrazepam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00243	0.0164	CbGeAlD
Flunitrazepam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00226	0.0153	CbGeAlD
Flunitrazepam—GABRA6—brain—amyotrophic lateral sclerosis	0.00224	0.0151	CbGeAlD
Flunitrazepam—GABRA5—brain—amyotrophic lateral sclerosis	0.00217	0.0147	CbGeAlD
Flunitrazepam—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00217	0.0146	CbGeAlD
Flunitrazepam—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.0021	0.0142	CbGeAlD
Flunitrazepam—GABRA3—brain—amyotrophic lateral sclerosis	0.00202	0.0136	CbGeAlD
Flunitrazepam—GABRA4—brain—amyotrophic lateral sclerosis	0.00197	0.0133	CbGeAlD
Flunitrazepam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00197	0.0133	CbGeAlD
Flunitrazepam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00191	0.0129	CbGeAlD
Flunitrazepam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.0019	0.0128	CbGeAlD
Flunitrazepam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00186	0.0125	CbGeAlD
Flunitrazepam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00183	0.0124	CbGeAlD
Flunitrazepam—TSPO—nervous system—amyotrophic lateral sclerosis	0.00182	0.0123	CbGeAlD
Flunitrazepam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00179	0.0121	CbGeAlD
Flunitrazepam—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00176	0.0119	CbGeAlD
Flunitrazepam—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00172	0.0116	CbGeAlD
Flunitrazepam—CYP2A6—brain—amyotrophic lateral sclerosis	0.00171	0.0115	CbGeAlD
Flunitrazepam—GABRA2—brain—amyotrophic lateral sclerosis	0.00151	0.0102	CbGeAlD
Flunitrazepam—GABRA1—brain—amyotrophic lateral sclerosis	0.00146	0.00982	CbGeAlD
Flunitrazepam—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.0014	0.00946	CbGeAlD
Flunitrazepam—TSPO—brain—amyotrophic lateral sclerosis	0.00139	0.00941	CbGeAlD
Flunitrazepam—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00125	0.00844	CbGeAlD
Flunitrazepam—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00112	0.00758	CbGeAlD
Flunitrazepam—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00108	0.00729	CbGeAlD
Flunitrazepam—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00105	0.00711	CbGeAlD
Flunitrazepam—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00101	0.00685	CbGeAlD
Flunitrazepam—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000992	0.00669	CbGeAlD
Flunitrazepam—CYP2B6—brain—amyotrophic lateral sclerosis	0.000859	0.00579	CbGeAlD
Flunitrazepam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000848	0.00572	CbGeAlD
Flunitrazepam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000817	0.00551	CbGeAlD
Flunitrazepam—CYP2E1—brain—amyotrophic lateral sclerosis	0.000806	0.00543	CbGeAlD
Flunitrazepam—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000482	0.00308	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000476	0.00304	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000476	0.00304	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000476	0.00304	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000473	0.00302	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000466	0.00298	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000466	0.00298	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00046	0.00294	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00046	0.00294	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000459	0.00293	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000459	0.00293	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000458	0.00293	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000454	0.0029	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00045	0.00288	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00045	0.00288	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00045	0.00288	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000445	0.00284	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000444	0.00284	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000443	0.00283	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000443	0.00283	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000442	0.00282	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000439	0.00281	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000434	0.00278	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000409	0.00261	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000406	0.00259	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000402	0.00257	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000401	0.00257	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000396	0.00253	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000395	0.00252	CbGpPWpGaD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000379	0.00242	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000377	0.00241	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000377	0.00241	CbGpPWpGaD
Flunitrazepam—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000376	0.0024	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000372	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00037	0.00237	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000367	0.00235	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000362	0.00231	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000362	0.00231	CbGpPWpGaD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000346	0.00221	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000343	0.00219	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000336	0.00215	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000331	0.00212	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000331	0.00211	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000327	0.00209	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000326	0.00209	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000322	0.00206	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000313	0.002	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000311	0.00199	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000308	0.00197	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000308	0.00197	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000308	0.00197	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000295	0.00189	CbGpPWpGaD
Flunitrazepam—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000291	0.00186	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00029	0.00185	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00029	0.00185	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000287	0.00183	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000285	0.00182	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000282	0.0018	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000281	0.0018	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000281	0.0018	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00028	0.00179	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000278	0.00177	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000278	0.00177	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000267	0.00171	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000264	0.00169	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000262	0.00167	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000262	0.00167	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000252	0.00161	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000251	0.0016	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00025	0.0016	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00025	0.0016	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000247	0.00158	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000247	0.00158	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000247	0.00158	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000246	0.00157	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000242	0.00155	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000242	0.00155	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000242	0.00154	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000241	0.00154	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000239	0.00153	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000238	0.00152	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000238	0.00152	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000229	0.00146	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000225	0.00144	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000223	0.00142	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00022	0.00141	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00022	0.0014	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000216	0.00138	CbGpPWpGaD
Flunitrazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000214	0.00137	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000213	0.00136	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000212	0.00136	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000211	0.00135	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000206	0.00132	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000206	0.00132	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000205	0.00131	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000204	0.00131	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000203	0.0013	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000203	0.0013	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000203	0.0013	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.0002	0.00128	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0002	0.00128	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000199	0.00127	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000198	0.00127	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000196	0.00125	CbGpPWpGaD
Flunitrazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000195	0.00125	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000193	0.00123	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000193	0.00123	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000193	0.00123	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000188	0.0012	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000183	0.00117	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000181	0.00116	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000181	0.00116	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000178	0.00114	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000176	0.00113	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000175	0.00112	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000169	0.00108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000166	0.00106	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000165	0.00105	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000164	0.00105	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000156	0.000995	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000156	0.000995	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000156	0.000995	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000155	0.000993	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000154	0.000986	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000153	0.000981	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000152	0.000974	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000152	0.000974	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000151	0.000968	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00015	0.000961	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000145	0.000925	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000142	0.00091	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00014	0.000896	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00014	0.000895	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000139	0.000891	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000139	0.000891	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000138	0.000882	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000137	0.000876	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000132	0.000846	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000132	0.000843	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000132	0.000842	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00013	0.000828	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000128	0.000817	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000127	0.000809	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000124	0.000795	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000122	0.000779	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000764	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000118	0.000754	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000118	0.000752	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000118	0.000752	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000113	0.000721	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000113	0.000719	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00011	0.000704	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00011	0.000701	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000108	0.000688	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000107	0.000685	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000107	0.000685	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000106	0.000676	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000104	0.000664	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0001	0.000639	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.0001	0.000639	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.81e-05	0.000627	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	9.75e-05	0.000623	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	9.4e-05	0.000601	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.23e-05	0.00059	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.16e-05	0.000586	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.16e-05	0.000586	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.12e-05	0.000583	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.1e-05	0.000582	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.57e-05	0.000548	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.55e-05	0.000546	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.53e-05	0.000545	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	8.5e-05	0.000543	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.38e-05	0.000536	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.35e-05	0.000534	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.08e-05	0.000517	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.01e-05	0.000512	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	7.87e-05	0.000503	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.79e-05	0.000498	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.75e-05	0.000496	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	7.71e-05	0.000493	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.43e-05	0.000475	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.33e-05	0.000468	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.07e-05	0.000452	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.07e-05	0.000452	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.87e-05	0.000439	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.63e-05	0.000423	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.47e-05	0.000413	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.46e-05	0.000413	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	6.44e-05	0.000412	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.33e-05	0.000405	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.32e-05	0.000404	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	6.11e-05	0.000391	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.01e-05	0.000384	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	5.95e-05	0.00038	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.88e-05	0.000376	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.65e-05	0.000361	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.58e-05	0.000357	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.42e-05	0.000347	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.42e-05	0.000346	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	5.2e-05	0.000332	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.13e-05	0.000328	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.11e-05	0.000327	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.02e-05	0.000321	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.94e-05	0.000316	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	4.88e-05	0.000312	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.63e-05	0.000296	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.46e-05	0.000285	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.45e-05	0.000285	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.31e-05	0.000275	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.22e-05	0.00027	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.22e-05	0.00027	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.19e-05	0.000268	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.06e-05	0.00026	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.96e-05	0.000253	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.88e-05	0.000248	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.81e-05	0.000243	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.58e-05	0.000229	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.56e-05	0.000228	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.47e-05	0.000222	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.47e-05	0.000222	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.4e-05	0.000217	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	3.26e-05	0.000208	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.19e-05	0.000204	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.13e-05	0.0002	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.05e-05	0.000195	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.94e-05	0.000188	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.89e-05	0.000185	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.78e-05	0.000178	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	2.63e-05	0.000168	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.62e-05	0.000168	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	2.57e-05	0.000164	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.41e-05	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.39e-05	0.000153	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.38e-05	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.23e-05	0.000143	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.2e-05	0.000141	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.05e-05	0.000131	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.98e-05	0.000127	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.81e-05	0.000116	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.8e-05	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.76e-05	0.000113	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.58e-05	0.000101	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.55e-05	9.88e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	9.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.36e-05	8.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.24e-05	7.93e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.19e-05	7.63e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.06e-05	6.77e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.18e-06	5.23e-05	CbGpPWpGaD
